Development of Hodgkins disease in the course of active chronic hepatitis treated by immunosuppressive drugs.
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000601:surgery; D006689:Hodgkin Disease / Q000209:etiology* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D013154:Spleen / Q000473:pathology
D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine